Results 31 to 40 of about 11,119 (206)

Hidradenitis suppurativa and psoriasis: the odd couple

Frontiers in Medicine, 2023
Psoriasis and hidradenitis suppurativa are chronic inflammatory skin diseases that can develop together, negatively impacting on the patient’s quality of life.
Laura Macca, Federica Li Pomi, Ylenia Ingrasciotta, Pietro Morrone, Gianluca Trifirò, Claudio Guarneri   +5 more
doaj   +1 more source

Development of core outcome sets in hidradenitis suppurativa:a systematic review of outcome measure instruments to inform the process [PDF]

, 2016
Background The recent hidradenitis suppurativa (HS) Cochrane review identified outcome measure heterogeneity as an important issue to address when designing future HS trials.
Hadjieconomou, Sofia, Ingram, John R., Piguet, Vincent   +2 more
core   +1 more source

Immunohistochemical Expression of Haptoglobin in Skin Lesions of Hidradenitis Suppurativa

Life
Background: Meta-inflammation is a hallmark of hidradenitis suppurativa (HS). Research on meta-inflammation in HS is growing, but there is still no research on haptoglobin as an inflammatory protein in lesional HS skin.
Nessr Abu Rached, Hanna Telkemeyer, Marina Skrygan, Martin Doerler, Yannik Haven, Lennart Ocker, Daniel Myszkowski, Thomas Meyer, Markus Stücker, Eggert Stockfleth, Falk G. Bechara   +10 more
doaj   +1 more source

Role of nutrition and adherence to the mediterranean diet in the multidisciplinary approach of hidradenitis suppurativa: Evaluation of nutritional status and its association with severity of disease [PDF]

, 2018
Hidradenitis suppurativa (HS) is a chronic, inflammatory and debilitating skin disorder. The exacerbating factors of HS include nutrition and adiposity.
Annunziata, Giuseppe, Barrea, Luigi, Colao, Annamaria, Donnarumma, Marianna, Fabbrocini, Gabriella, Marasca, Claudio, Muscogiuri, Giovanna, Savastano, Silvia   +7 more
core   +1 more source

Hidradenitis Suppurativa: Higher Tobacco Pack-Years in Patients with Metabolic Comorbidities

Life
Background: Hidradenitis suppurativa (HS) is a chronic, relapsing inflammatory dermatosis with substantial quality-of-life impact. HS frequently co-exists with obesity and metabolic comorbidities. Cigarette smoking is highly prevalent and has been linked
Yannik Haven, Nessr Abu Rached, Charlotte Michel, Daniel Myszkowski, Lennart Ocker, Ioannis A. Zeglis, Eggert Stockfleth, Falk G. Bechara   +7 more
doaj   +1 more source

Case for diagnosis [PDF]

, 2011
O termo úlcera de Marjolin é usado para designar a transformação maligna que se origina na pele cronicamente lesada. Trata-se de neoplasia mais agressiva do que aquelas não relacionadas com cicatriz e, frequentemente, é subdiagnosticada ou tratada de ...
ALMEIDA, José Roberto Paes de, DINATO, Marcelo Mattos e, DINATO, Sandra Lopes Mattos e, NÓVOA, Estela Gemha de, ROMITI, Ney   +4 more
core   +3 more sources

Sertraline and Phenytoin Drug Interaction in a Geriatric Patient [PDF]

, 2017
This report presents the case of a 78-year-old man residing in a nursing home who presented with a 2-month history of increasing lethargy and confusion. These symptoms coincided with the initiation of sertraline in the patient.
Caprio, Thomas V., DiLoreto, Stefanie E., Hopkins, Heather A., Nathan, Kobi T, Ta, Nhon A.   +4 more
core   +2 more sources

Efficacy of Ritlecitinib for Vitiligo Treatment Stratified by Baseline Demographic and Clinical Characteristics: Post Hoc Analysis of a Phase 2b Study

JEADV Clinical Practice, EarlyView.
This post hoc analysis examined the efficacy of ritlecitinib in subgroups of patients with vitiligo, defined by demographic and clinical characteristics. Patients completed the dose‐ranging and extension periods of the phase 2b study (NCT03715829) of ritlecitinib.
A. G. Pandya, I. Hamzavi, P. Ghosh, K. Ezzedine, J. E. Harris, R. Adiri, S. Chen, E. Peeva, Y. Yamaguchi   +8 more
wiley   +1 more source

Dermatoveneroloogia [PDF]

, 2016
Eesti Arst 2016; 95(8):544 ...
Volke, Annika
core   +2 more sources

Safety and Effectiveness of Percutaneous Ultrasound-Guided Galvanic Current in Tunnels of Patients with Hidradenitis Suppurativa: A Pilot Study

Dermatology and Therapy
Introduction The recurrent nature of hidradenitis suppurativa (HS), even under maintained systemic treatment, makes it necessary to have effective local treatments; however, the response to these therapies is variable (44–81%).
Alberto Soto-Moreno, Carlos Cuenca-Barrales, Salvador Arias-Santiago, José Antonio García-Vidal, Francesc Medina-Mirapeix, Alejandro Molina-Leyva   +5 more
doaj   +1 more source